Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Impact of the exon 3-deleted GH receptor polymorphism on baseline height and the growth response to recombinant human growth hormone therapy in growth hormone deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis
Journal of Clinical Endocrinology and Metabolism, 07/08/09
Wassenaar MJE et al. - The meta-analysis in prepubertal children with short stature indicates that GHRd3 is associated with increased baseline height in GHD, but not in non-GHD. Furthermore, GHRd3 stimulates growth velocity by an additional effect of 0.5 cm during the first year of rhGH treatment and this effect is more pronounced at lower doses of rhGH and higher age.
Related Articles
The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly
Journal of Clinical Endocrinology and Metabolism, 11/12/09
Relevance Score: 79%
Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy
Journal of Clinical Oncology, 11/12/09
Relevance Score: 79%
Pathogenesis of adolescent idiopathic scoliosis in girls - a double neuro-osseous theory involving disharmony between two nervous systems, somatic and autonomic expressed in the spine and trunk: possible dependency on sympathetic nervous system and hormones with implications for medical therapy
Scoliosis, 11/02/09
Relevance Score: 79%
Prader-Willi syndrome: clinical features and management
Paediatrics and Child Health, 10/07/09
Relevance Score: 79%
Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III tandem study
Journal of Clinical Oncology, 10/01/09
Relevance Score: 79%
Today in Metabolism and Growth...keeping you current
Receive free subspecialty "5-minute updates" via email
Is Diabetic Ketoacidosis at Disease Onset a Result of Missed Diagnosis
The Journal of Pediatrics, 12/08/09
Metabolic Risk Profiles and Associated Risk Factors Among Vietnamese Adults in Ho Chi Minh City
Metabolic Syndrome and Related Disorders, 12/03/09
Prediction of Adult Height Based on Automated Determination of Bone Age
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Today in Pediatric Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Insulin Resistance and Metabolic Syndrome in the Pediatric Population
Metabolic Syndrome and Related Disorders, 12/08/09
Effects of Pediatric Obesity on Joint Kinematics and Kinetics During 2 Walking Cadences
Archives of Physical Medicine and Rehabilitation, 12/08/09
Is Diabetic Ketoacidosis at Disease Onset a Result of Missed Diagnosis
The Journal of Pediatrics, 12/08/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Pituitary, 12/08/09
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/08/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Sponsor
Article Search
Sponsor


See Latest Articles


